PD
DNTH icon

Point72 (DIFC)’s Dianthus Therapeutics DNTH Stock Holding History

Point72 (DIFC)’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$114K Sell
2,901
-6,012
-67% -$154K 0.01% 552
2025
Q2 		$166K Sell
8,913
-7,835
-47% -$147K 0.01% 821
2025
Q1 		$304K Buy
16,748
+2,735
+20% +$60.3K 0.01% 773
2024
Q4 		$305K Buy
14,013
+1,539
+12% +$39.6K 0.01% 774
2024
Q3 		$342K Sell
12,474
-426
-3% -$11.9K 0.01% 740
2024
Q2 		$334K Buy
+12,900
New +$310K 0.01% 747

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return